Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Motala

4 clinical trials in Motala, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Motala at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Motala

Open in trial search
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Hypochlorite
  • Sponsor:University Of Gothenburg
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Region Oestergoetland

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.
Investigational
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Tolebrutinib
  • Sponsor:Genzyme Corp.

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Motala

What the registry says about research in the country

01 Orthopedic Research

Innovative research focusing on reducing infection risks in hip arthroplasty through the evaluation of antibiotic-impregnated bone grafts. This groundbreaking study aims to enhance patient outcomes in joint replacement procedures.

  • Prosthetic Joint Infection Prevention
  • Bone Graft Technology
  • Surgical Innovation

The research explores advanced infection prevention strategies in orthopedic surgeries.

02 Wound Care Management

Clinical investigation comparing antimicrobial treatments for diabetic foot ulcers, evaluating the effectiveness of different therapeutic agents in wound healing processes.

  • Diabetic Wound Care
  • Antimicrobial Therapy
  • Healing Time Assessment

This research aims to improve treatment outcomes for patients with chronic diabetic wounds.

03 Neurology Studies

Advanced research into Primary Progressive Multiple Sclerosis treatment, examining innovative therapeutic approaches using BTK inhibitors to delay disease progression.

  • Multiple Sclerosis Treatment
  • Neurological Disease Management
  • Disability Progression Control

The study focuses on breakthrough treatments for progressive neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.